Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD Env particle release activity

Journal of Virology

Volumn 73, Issue 1, 1999, Pages 778-782

  Bour, Stephan P ^a   Aberham, Claudia ^a   Perrin, Christele ^a   Strebel, Klaus ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; VIRUS ENVELOPE;

EID: 0032889496     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.1.778-782.1999     Document Type: Article

References (18)

1. Barnett, S. W., M. Quiroga, A. Werner, D. Dina, and J. A. Levy. 1993. Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain. J. Virol. 67:1006-1014.
2. Bour, S., U. Schubert, K. Peden, and K. Strebel. 1996. The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? J. Virol. 70:820-829.
3. Bour, S., and K. Strebel. Unpublished data.
4. Bour, S., and K. Strebel. 1996. The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV Type 1 Vpu that enhances particle release of heterologous retroviruses. J. Virol. 70:8285-8300.
5. Clarel, F., D. Guétard, F. Brun-Vézinet, S. Chamaret, M. A. Rey, M. O. Santos-Ferreira, A. G. Laurent, C. Dauguet, C. Katlama, C. Rouzioux, D. Klatzmann, J. L. Champalimaud, and L. Montagnier. 1986. Isolation of a new human retrovirus from West African patients with AIDS. Science 233:343-346.
6. Clavel, F., M. Guyader, D. Guétard, M. Salle, L. Montagnier, and M. Alizon. 1986. Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature 324:691-695.
7. Cohen, E. A., E. F. Terwilliger, J. G. Sodroski, and W. A. Haseltine. 1988. Identification of a protein encoded by the vpu gene of HIV-1. Nature 334:532-534.
8. Göttlinger, H. G., T. Dorfman, E. A. Cohen, and W. A. Haseltine. 1993. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA 90:7381-7385.
9. Guyader, M., M. Emerman, P. Sonigo, F. Clarel, L. Montagnier, and M. Alizon. 1987. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 326:662-669.
10. Ishikawa, K., H. Tsujimoto, M. Nakai, J. A. Mingle, M. Osei-Kwasi, S. E. Aggrey, V. B. Nettey, S. N. Afoakwa, M. Fukasawa, T. Kodama, et al. 1988. Isolation and characterization of HIV-2 from an AIDS patient in Ghana. AIDS 2:383-388.
11. Kong, L. I., S. W. Lee, J. C. Kappes, J. S. Parkin, D. Decker, J. A. Hoxie, B. H. Hahn, and G. M. Shaw. 1988. West African HIV-2-related human retrovirus with attenuated cytopathicity. Science 240:1525-1529.
12. Kumar, P., H. Hui, J. C. Kappes, B. S. Haggarty, J. A. Hoxie, S. K. Arya, G. M. Shaw, and B. H. Hahn. 1990. Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate. J. Virol. 64:890-901.
13. Mulligan, M. J., G. V. Vamshchikov, G. Ritter, Jr., F. Gao, M. J. Jin, C. D. Nail, C. P. Spies, B. H. Hahn, and R. W. Compans. 1992. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J. Virol. 66:3971-3975.
14. mac. J. Virol. 62:4691-1696.
15. Ritter, G. D., Jr., G. Yamshchikov, S. J. Cohen, and M. J. Mulligan. 1996. Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain. J. Virol. 70:2669-2673.
16. Ryan-Graham, M. A., and W. C. K. Peden. 1995. Both virus and host components are important for the manifestation of a Nef-minus phenotype in HIV-1 and HIV-2. Virology 213:158-168.
17. Schnell, M. J., L. Buonocore, E. Boritz, H. P. Ghosh, R. Chernish, and J. K. Rose. 1998. Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. EMBO J. 17:1289-1296.
18. Schubert, U., S. Bour, A. V. Ferrer-Montiel, M. Montal, F. Maldarelli, and K. Strebel. 1996. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70:809-819.